Kodiak Sciences, Inc. (KOD)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$35.36-2.75%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · KOD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||||
| R&D Expenses | 200.6 | 182.4 | 126.1 | 206.3 | 267.6 | 217.3 | 107.4 | 37.5 | 18.8 |
| Operating Income | (246.4) | (234.4) | (186.8) | (277.3) | (341.4) | (267.1) | (136.0) | (49.2) | (26.4) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.5 |
| Interest & Investment Income | 4.6 | 4.5 | 11.1 | 16.7 | 7.1 | 0.3 | 3.0 | 1.6 | — |
| Net Interest Expenses | — | — | — | (16.7) | (7.1) | (0.3) | (2.9) | (1.6) | — |
| EBT, Incl. Unusual Items | — | (229.9) | (176.2) | (260.4) | (333.8) | (266.9) | (133.1) | (47.4) | (41.4) |
| Income Tax Expense | — | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | — | — |
| Net Income | |||||||||
| Net Income | (242.0) | (230.0) | (176.2) | (260.5) | (333.8) | (267.0) | (133.1) | (47.4) | (41.4) |
| Per Share | |||||||||
| Basic EPS | (3.86) | (4.32) | (3.35) | (4.97) | (6.39) | (5.16) | (2.91) | — | — |
| Diluted EPS | (3.86) | (4.32) | (3.35) | (4.97) | (6.39) | (5.16) | (2.91) | — | — |
| Basic Weighted Avg Shares | 62.6 | 53.2 | 52.6 | 52.4 | 52.2 | 51.8 | 45.7 | — | — |
| Diluted Weighted Avg Shares | 62.6 | 53.2 | 52.6 | 52.4 | 52.2 | 51.8 | 45.7 | — | — |
| Supplemental | |||||||||
| EBIT | (246.4) | (234.4) | (186.8) | (277.3) | (341.4) | (267.1) | (136.0) | (49.2) | (26.4) |
| Effective Tax Rate | — | — | — | -0.0% | -0.0% | -0.0% | -0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.